longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

HINSANG GROUP

06893

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Weekly Recap | DUALITYBIO-B -6.91%, most brokers rate it buy

    Weekly Review·1 day ago, 05:46 AM
    09606-0.76%
  • Weekly Recap | IMPACT THERAP-B -18.92%, pop then fade

    Weekly Review·1 day ago, 05:42 AM
    07630-5.13%
  • Weekly Recap | BEONE MEDICINES -0.37%, most brokers rate it buy

    Weekly Review·1 day ago, 05:37 AM
    06160+0.56%
  • Weekly Recap | HENLIUS -11.39%, most brokers rate it buy

    Weekly Review·1 day ago, 05:22 AM
    02696-0.78%
  • Weekly Recap | BIOCYTOGEN-B -0.36%, a choppy flat week

    Weekly Review·1 day ago, 05:13 AM
    02315+0.96%
  • Weekly Recap | HBM HOLDINGS-B -9.22%, most brokers rate it buy

    Weekly Review·1 day ago, 05:11 AM
    02142-0.36%